Phytochemical Constituents of Annona Species as Promising Bioactive Promising Bioactive Principle in Pain and Inflammation

Pain and inflammation are complex physiological responses that play critical roles in tissue protection and healing. However, persistent or chronic inflammation contributes to the pathogenesis of numerous disorders, including arthritis, cardiovascular diseases, neurodegenerative conditions, and metabolic syndromes ⁽¹⁾. Conventional pharmacological interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and opioid analgesics are widely employed for the management of pain and inflammatory disorders. Nevertheless, their long-term use is frequently associated with adverse effects, including gastrointestinal ulceration, renal toxicity, cardiovascular complications, and dependence. Consequently, there is growing interest in the discovery of safer and more effective therapeutic agents from natural sources.

Medicinal plants have historically served as valuable reservoirs of bioactive compounds with diverse pharmacological properties. Among these, the genus Annona (family Annonaceae) has attracted considerable scientific attention due to its rich phytochemical diversity and broad spectrum of biological activities. The genus comprises more than 100 species distributed predominantly in tropical and subtropical regions, with important medicinal species including Annona muricata, Annona squamosa, Annona reticulata, Annona cherimola, and Annona senegalensis. Various parts of these plants, such as leaves, bark, roots, seeds, and fruits, have been extensively utilized in traditional medicine for the treatment of pain, inflammation, fever, infections, diabetes, and other ailments ⁽²⁾.

Phytochemical investigations have revealed that Annona species are rich sources of numerous secondary metabolites, including annonaceous acetogenins, alkaloids, flavonoids, phenolic compounds, terpenoids, tannins, essential oils, and glycosides. These phytoconstituents exhibit a wide range of pharmacological activities, such as antioxidant, anti-inflammatory, analgesic, antimicrobial, neuroprotective, and anticancer effects^{. (3)} In particular, flavonoids and phenolic compounds have demonstrated the ability to modulate inflammatory mediators and oxidative stress pathways, whereas alkaloids and acetogenins contribute to diverse biological responses associated with pain and inflammation control.

Several experimental studies have reported significant analgesic and anti-inflammatory activities of extracts and isolated compounds from Annona species. For example, Annona muricata has been traditionally employed for the management of pain and inflammatory disorders and has demonstrated anti-inflammatory and analgesic effects in preclinical models. Similar pharmacological properties have also been reported. These activities are believed to arise from synergistic interactions among multiple phytochemicals capable of regulating inflammatory cytokines, cyclooxygenase pathways, nitric oxide production, and reactive oxygen species generation^{. (4)}

Given the increasing demand for plant-derived therapeutics and the expanding body of evidence regarding the biological activities of Annona phytochemicals, a comprehensive evaluation of their role in pain and inflammation is warranted. Therefore, this review aims to summarize the major phytochemical constituents identified in Annona species and critically discuss their potential as promising bioactive principles for the management of pain and inflammatory disorders, highlighting current evidence, mechanisms of action, and future research perspectives^{. (5)}

ETHANOBOTANICAL FEATURES

Annona squamosa (Sugar Apple / Custard Apple)

Annona squamosa is one of the most extensively utilized Annona species in traditional medicine across India, Southeast Asia, Africa, and South America. The leaves are commonly used as poultices for wounds, ulcers, boils, and skin infections. Decoctions of leaves and bark are traditionally administered for dysentery, diarrhoea, diabetes, fever, and rheumatism. The seeds are widely employed as insecticides and for treating lice infestations, while the fruits are consumed as nutritive tonics and digestive aids. In Ayurvedic and folk medicine, various parts of the plant are also used as anthelmintic, antimicrobial, and anti-inflammatory remedies. Ethnobotanical surveys indicate that rural communities frequently use leaf preparations to manage diabetes and hypertension. ⁽⁶⁾

Annona muricata (Soursop / Graviola)

Annona muricata has a rich ethnomedicinal history throughout the Caribbean, Central and South America, Africa, and Asia. Traditional healers use the leaves as sedatives and remedies for insomnia, headaches, hypertension, diabetes, and inflammatory disorders. Fruit pulp is used for treating fever, diarrhoea, dysentery, intestinal parasites, rheumatism, and postpartum weakness. Crushed seeds are employed as antiparasitic agents, while bark and root decoctions are used against infections and fever. Indigenous populations have long used different parts of the plant for cancer-related ailments, although scientific evidence remains under investigation. ⁽⁷⁾

Annona reticulata (Bullock's Heart / Custard Apple)

Annona reticulata is traditionally used in India, the Caribbean, Central America, and Southeast Asia. The leaves are applied externally to treat abscesses, wounds, and skin diseases. Root and bark preparations are used for epilepsy, dysentery, diarrhoea, and helminth infections. Folk practitioners employ the fruits as nutritional supplements and digestive stimulants. In traditional Indian medicine, leaf extracts are also used for reducing pain, inflammation, and fever. Seeds are utilized as insecticidal agents and for controlling ectoparasites. ⁽⁸⁾

Annona cherimola (Cherimoya)

In the Andean regions of Peru, Ecuador, and Bolivia, Annona cherimola has been used traditionally for gastrointestinal disorders, digestive complaints, and parasitic infections. Infusions of leaves are consumed for anxiety, nervousness, and insomnia. The fruits are regarded as restorative foods and are frequently prescribed during recovery from illness. Seeds have historically been used as insecticides and antiparasitic agents, although their toxicity limits medicinal use. Traditional healers also employ leaf preparations for respiratory ailments and inflammatory conditions. ⁽⁹⁾

Annona diversifolia (Ilama)

Native to Central America and Mexico, Annona diversifolia is used in traditional medicine mainly for gastrointestinal disorders, fever, and inflammatory conditions. Indigenous communities consume fruit pulp as a strengthening food and use leaf infusions to alleviate digestive discomfort and mild infections. Ethnobotanical reports also describe its use for improving general health and treating stomach ailments. ⁽¹⁰⁾

Annona glabra (Pond Apple)

Annona glabra is employed in folk medicine in Central America, the Caribbean, and parts of South America. Traditional uses include treatment of intestinal disorders, parasitic infections, and inflammatory diseases. Bark and leaf preparations are commonly used for wound healing and fever management. Some indigenous groups use seed extracts as insecticidal preparations. ⁽¹¹⁾

Annona montana (Mountain Soursop)

Traditional communities in tropical America use Annona montana leaves, bark, and fruits to treat fever, infections, rheumatic pain, and digestive disturbances. Leaf decoctions are frequently employed as anti-inflammatory remedies, while fruit preparations are used as nutritional supplements and tonics. ⁽¹²⁾

Fig :1 explains the of various parts of Annona species indicating ethnobotanical uses and traditional uses

FIG:2   Phytochemical constituents of different parts of Annona species

CONCLUSION       

The present review consolidates substantial ethnobotanical, phytochemical, and pharmacological evidence supporting the traditional use of Annona species including A. squamosa, A. muricata, A. reticulata, A. cherimola, A. senegalensis, A. glabra, A. montana, and A. diversifolia in the management of pain and inflammatory conditions. These findings position Annona-derived phytoconstituents as potential disease-modifying alternatives to NSAIDs, corticosteroids, and opioids, whose long-term use carries gastrointestinal, renal, cardiovascular, and dependence-related risks. However, evidence remains largely preclinical. Future research should focus on isolating and characterizing the active compounds, clarifying their molecular mechanisms, conducting toxicological evaluation, and pursuing clinical trials to validate their therapeutic potential for both pain, Acute and chronic inflammatory diseases.   

REFERENCES

1. Kusmardiyani S, Suharli YA, Insanu M, Fidrianny I. Phytochemistry and pharmacological activities of Annona genus: A review. Current Research on Biosciences and Biotechnology. 2020 Aug 31;2(1):77-88.
2. Nugraha AS, Damayanti YD, Wangchuk P, Keller PA. Anti-infective and anti-cancer properties of the Annona species: Their ethnomedicinal uses, alkaloid diversity, and pharmacological activities. Molecules. 2019 Dec 3;24(23):4419.
3. Moghadamtousi SZ, Fadaeinasab M, Nikzad S, Mohan G, Ali HM, Kadir HA. Annona muricata (Annonaceae): a review of its traditional uses, isolated acetogenins and biological activities. International journal of molecular sciences. 2015 Jul 10;16(7):15625-58.
4. Soheil Zorofchian Moghadamtousi SZ, Mehran Fadaeinasab MF, Sonia Nikzad SN, Gokula Mohan GM, Hapipah Mohd Ali HM, Habsah Abdul Kadir HA. Annona muricata (Annonaceae): a review of its traditional uses, isolated acetogenins and biological activities.
5. Chowdhury SS, Tareq AM, Tareq SM, Farhad S, Sayeed MA. Screening of antidiabetic and antioxidant potential along with phytochemicals of Annona genus: A review. Future Journal of Pharmaceutical Sciences. 2021 Jul 19;7(1):144.
6. Singh RP, Pattnaik AK, Rudrapal M, Bhattacharya S. Annona squamosa Linn.: A review of its ethnobotany, pharmacology, phytochemistry, toxicity, and conservation needs. Pharmacognosy Magazine. 2025 Jun;21(2):403-12.
7. Moghadamtousi SZ, Fadaeinasab M, Nikzad S, Mohan G, Ali HM, Kadir HA. Annona muricata (Annonaceae): a review of its traditional uses, isolated acetogenins and biological activities. International journal of molecular sciences. 2015 Jul 10;16(7):15625-58.
8. Leite DO, de FA Nonato C, Camilo CJ, de Carvalho NK, da Nobrega MG, Pereira RC, da Costa JG. Annona genus: traditional uses, phytochemistry and biological activities. Current Pharmaceutical Design. 2020 Sep 1;26(33):4056-91.
9. Scheldeman X, Van Damme P, Motoche JR, Alvarez JU. Germplasm collection and fruit characterisation of cherimoya (Annona cherimola) in Loja Province, Ecuador, an important centre of biodiversity. Belgian Journal of Botany. 2006 Jan 1:27-38.
10. Soleman DM, Eldahshan OA, Saleh ME, Elkousy RH. An Updated Review of the Genus Annona: Ethnomedicinal Applications, Phytochemical Profiles, and Therapeutic Potentials. Azhar International Journal of Pharmaceutical and Medical Sciences. 2026 Jan 1;6(1):1-
11. Sánchez-García EA, López-Rosas H, Infante-Mata D, Moreno-Casasola P. Annona glabra L., a key swamp tree: Ecological, functional, and ethnobotanical aspects for conservation and restoration. Botanical Sciences. 2026;104(SPE):26-55
12. M. Barbalho S, Alvares Goulart RD, Maria Vasques Farinazzi-Machado F, da Silva Soares de Souza M, Cincotto dos Santos Bueno P, Landgraf Guiguer E, Cressoni Araujo A, Groppo M. Annona sp: Plants with multiple applications as alternative medicine-A Review. Current Bioactive Compounds. 2012 Sep 1;8(3):277-86.
13. Moussa AY, Siddiqui SA, Elhawary EA, Guo K, Anwar S, Xu B. Phytochemical constituents, bioactivities, and applications of custard apple (Annona squamosa L.): A narrative review. Food Chemistry. 2024 Nov 30; 459:140363.
14. do Nascimento Silva H, Rabêlo SV, Diniz TC, da Silva Oliveira FG, de Andrade Teles RB, Silva JC, e Silva MG, Coutinho HD, de Menezes IR, da Silva Almeida JR. Antinociceptive and anti-inflammatory activities of ethanolic extract from atemoya (Annona cherimola Mill x Annona squamosa L.). African Journal of Pharmacy and Pharmacology. 2017 May 15;11(18):224-32.
15. Kazman BS, Harnett JE, Hanrahan JR. The phytochemical constituents and pharmacological activities of Annona atemoya: a systematic review. Pharmaceuticals. 2020 Sep 24;13(10):269.
16. Chavan MJ, Wakte PS, Shinde DB. Analgesic and anti-inflammatory activities of the sesquiterpene fraction from Annona reticulata L. bark. Natural product research. 2012 Aug 1;26(16):1515-8.
17. Thang TD, Kuo PC, Huang GJ, Hung NH, Huang BS, Yang ML, Luong NX, Wu TS. Chemical constituents from the leaves of Annona reticulata and their inhibitory effects on NO production. Molecules. 2013 Apr 16;18(4):4477-86.
18. Roslida AH, Tay CE, Zuraini A, Chan PF. Anti-inflammatory and anti-nociceptive activities of the ethanolic extract of Annona muricata leaf.
19. Barboza FS, Sarr A, Outouen DT, Wele A, Bassene E, SY GY. Analgesic and anti-inflammatory activity of methanolic fraction of total ethereal leaf extract of Annona senegalensis Pers. (Annonaceae). African Journal of Pharmacy and Pharmacology. 2017 Feb 28;11(8):120-4.
20. De Sousa OV, Vieira GD, de Jesus RG de Pinho J, Yamamoto CH, Alves MS. Antinociceptive and anti-inflammatory activities of the ethanol extract of Annona muricata L. leaves in animal models. International journal of molecular sciences. 2010 May 6;11(5):2067-78.
21. Ishola IO, Awodele O, Olusayero AM, Ochieng CO. Mechanisms of analgesic and anti-inflammatory properties of Annona muricata Linn. (Annonaceae) fruit extract in rodents. Journal of medicinal food. 2014 Dec;17(12):1375-82.
22. Olufunsho A, Micheal OA. Mechanisms of Analgesic and Anti-Inflammatory Properties of Annona muricata Linn. (Annonaceae) Fruit Extract in Rodents.
23. Thang TD, Kuo PC, Huang GJ, Hung NH, Huang BS, Yang ML, Luong NX, Wu TS. Chemical constituents from the leaves of Annona reticulata and their inhibitory effects on NO production. Molecules. 2013 Apr 16;18(4):4477-86. doi: 10.3390/molecules18044477. PMID: 23591927; PMCID: PMC6270106.
24. Rout SP, Kar DM. Identification of chemical compounds present in different fractions of Annona reticulata L. leaf by using GC-MS. Nat Prod Res. 2014;28(20):1786-8. doi: 10.1080/14786419.2014.939084. Epub 2014 Jul 22. PMID: 25050939.
25. Pino JA, Marbot R, Fuentes V. Characterization of volatiles in bullock's heart (Annona reticulata L.) fruit cultivars from Cuba. Journal of agricultural and food chemistry. 2003 Jun 18;51(13):3836-9.
26. Abdul Wahab SM, Jantan I, Haque MA, Arshad L. Exploring the leaves of Annona muricata L. as a source of potential anti-inflammatory and anticancer agents. Frontiers in pharmacology. 2018 Jun 20; 9:661.
27. Zeng L, Wu FE, Oberlies NH, McLaughlin JL, Sastrodihadjo S. Five new monotetrahydrofuran ring acetogenins from the leaves of Annona muricata. Journal of Natural Products. 1996 Nov 22;59(11):1035-42.
28. Yu JG, Gui HQ, Luo XZ, Sun L. Murihexol, a linear acetogenins from Annona muricata. Phytochemistry. 1998 Nov 20;49(6):1689-92.
29. Wu YC, Hung YC, Chang FR, Cosentino M, Wang HK, Lee KH. Identification of ent-16β, 17-dihydroxykauran-19-oic acid as an anti-HIV principle and isolation of the new diterpenoids annosquamosins A and B from Annona squamosa. Journal of natural products. 1996 Jun 22;59(6):635-7.
30. Bonneau N, Baloul L, ba Ndob IB, Sénéjoux F, Champy P. The fruit of Annona squamosa L. as a source of environmental neurotoxins: From quantification of squamocin to annotation of Annonaceous acetogenins by LC–MS/MS analysis. Food Chemistry. 2017 Jul 1; 226:32-40.
31. Baskaran revathy. Characterization of free, esterified and bound phenolics in custard apple (Annona squamosa L) fruit pulp by UPLC-ESI-MS/MS. doi: 10.1016/J.FOODRES.2016.02.001.
32. Miyashita H, Nishida M, Okawa M, Nohara T, Yoshimitsu H. Four new ent-kaurane diterpenoids from the fruits of Annona cherimola. Chemical and Pharmaceutical Bulletin. 2010 May 1;58(5):765-8.
33. Santos SA, Vilela C, Camacho JF, Cordeiro N, Gouveia M, Freire CS, Silvestre AJ. Profiling of lipophilic and phenolic phytochemicals of four cultivars from cherimoya (Annona cherimola Mill.). Food chemistry. 2016 Nov 15; 211:845-52.
34. Gutiérrez Vázquez MT, García Durán A, Rodríguez Mejías FJ, González Molinillo JM, Megias D, Martínez Valdivia MJ, Macías Domínguez FA. Bio-Guided Isolation of Acetogenins from Annona cherimola Deciduous Leaves: Production of Nanocarriers to Boost the Bioavailability Properties
35. Calzada F, Ruedaflores YL, Mendieta-Wejebe JE, Ramírez-Santos J, Valdes M, Velázquez C, Barbosa E. Understanding the Antihyperglycemic Activity of Annona cherimola Leaves. An Edible and Medicinal Plant in Mexico: In Vivo and Ex-Vivo Studies. Molecules. 2026 Apr 23;31(9):1393.
36. Okoye TC, Akah PA, Okoli CO, Ezike AC, Omeje EO, Odoh UE. Antimicrobial effects of a lipophilic fraction and kaurenoic acid isolated from the root bark extracts of Annona senegalensis. Evidence‐Based Complementary and Alternative Medicine. 2012;2012(1):831327.
37. Tamfu AN, Tagatsing Fotsing M, Talla E, Jabeen A, Mbafor Tanyi J, Shaheen F. Bioactive constituents from seeds of Annona Senegalensis Persoon (Annonaceae). Nat Prod Res. 2021 May;35(10):1746-1751. doi: 10.1080/14786419.2019.1634713. Epub 2019 Jun 28. PMID: 31250675.
38. Matsumoto S, Varela RM, Palma M, Molinillo JM, Lima IS, Barroso CG, Macías FA. Bio-guided optimization of the ultrasound-assisted extraction of compounds from Annona glabra L. leaves using the etiolated wheat coleoptile bioassay. Ultrasonics sonochemistry. 2014 Jul 1;21(4):1578-84.
39. Hien NT, Nhiem NX, Yen DT, Hang DT, Tai BH, Quang TH, Tuan Anh HL, Kiem PV, Minh CV, Kim EJ, Kim SH, Kang HK, Kim YH. Chemical constituents of the Annona glabra fruit and their cytotoxic activity. Pharm Biol. 2015;53(11):1602-7. doi: 10.3109/13880209.2014.993042. Epub 2015 Apr 9. PMID: 25856711.
40. De Oliveira LC. Plants with anticonvulsant properties: a review. Revista Brasileira de Farmacognosia. 2008 Jan